Taysha Gene Therapies, Inc. (TSHA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Taysha Gene Therapies, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -16.13x | -4.85x | -1.84x | -0.60x | -2.51x | -10.90x |
| P/B Ratio | 7.12x | 6.05x | 2.74x | 104.67x | 4.60x | 1.87x |
| P/S Ratio | 179.93x | 51.93x | 13.30x | 39.70x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 0.6% | 0.0% | 0.0% |
| Operating Margin | -1130.6% | -1097.6% | -468.8% | -5037.1% | 0.0% | 0.0% |
| Net Margin | -1115.3% | -1071.6% | -722.1% | -6635.3% | 0.0% | 0.0% |
| EBITDA Margin | -1102.9% | -1055.5% | -680.8% | -6384.1% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 12.23x | 5.42x | 4.08x | 1.54x | 3.08x | 36.17x |
| Quick Ratio | 12.23x | 5.42x | 4.08x | 1.54x | 3.08x | 36.17x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.88x | 0.82x | 63.15x | 0.66x | 0.00x |
YoY = year-over-year change. Source: FMP..